344
Participants
Start Date
July 11, 2023
Primary Completion Date
July 2, 2024
Study Completion Date
July 2, 2024
Investigational Site Number : 2880001, Navrongo
Investigational Site Number : 2880002, Kintampo
Investigational Site Number : 7640001, Ratchathewi
Investigational Site Number : 3400001, Tegucigalpa
Investigational Site Number : 3400002, San Pedro Sula
Investigational Site Number : 7240001, Móstoles
Investigational Site Number : 2460003, Tampere
Investigational Site Number : 2460004, Kokkola
Investigational Site Number : 7640002, Songkhla
Investigational Site Number : 3560002, Pune
Investigational Site Number : 3560001, Mysuru
Quality Clinical Research - 10040 Regency Cir - HyperCore - PPDS Site Number : 8400001, Omaha
Senders Pediatrics Site Number : 8400002, Cleveland
Investigational Site Number : 2460002, Helsinki
Investigational Site Number : 2460001, Järvenpää
Sanofi Pasteur, a Sanofi Company
INDUSTRY